Alex Delaney-Gesing 

home

authors

alex-delaney-gesing

Chuck Hess, vice president and general manager, U.S. Surgical (Bausch +Lomb), shares an update on Bausch + Lomb's latest developments in surgical technology — including ClearVisc™, a dispersive ophthalmic viscosurgical device — as well as how the company has adapted its operations during the pandemic.

Videos

Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.

Surgical updates for Bausch + Lomb 


Mitch Shultz, MD, Chang Shultz Vision (Northridge, CA), speaks on the capabilities of eyeTELLIGENCE™ (Bausch + Lomb), a cloud-based database system, combined with Stellaris Elite (Bausch + Lomb) vision enhancement systems, to look at energy-fluid metrics,  provide surgeons with the capacity to refine procedures, and give patients better outcomes. 

Mitch Shultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, provide surgeons with the capacity to refine procedures and give patients better outcomes. 

Refining surgical procedures with cloud-based analytical software

Elizabeth Yeu, MD, a cornea cataract and refractive surgeon at Virginia Eye Consultants, shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of a new investigational therapeutic from Tarsus Pharmaceuticals called TP03 (lotilaner ophthalmic solution 0.25%), for the treatment of patients diagnosed with Demodex blepharitis.

Podcasts

Elizabeth Yeu, MD, shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of TP03 for the treatment of patients diagnosed with Demodex blepharitis.

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Colman R. Kraff, MD, of Kraff Eye Institute (Chicago, IL), shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio, a new topography-integrated, wavefront-guided LASIK procedure, for the treatment of patients with hyperopia and myopia. 
 



Disclaimer/Notes: Dr. Kraff presented this data on behalf of the International Medical Advisory Board for Optical Express. This study was conducted in the United Kingdom and Ireland.

Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia. 

Alex Delaney-Gesing

Articles

Refining surgical procedures with cloud-based analytical software

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Outcomes of LASIK utilising new topography-integrated aberrometer

Surgical updates for Bausch + Lomb